4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-21-060752
EVP and General Counsel sold 310 shares at $81.14 ($25,153)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Parschauer Karah Herdman EVP and General Counsel | 2021-10-14 | Sale | −310 | $81.14 | $25,153 | 28,358 | D: show line 1 in the form |
| Open-market sales · 310 sh · avg $81.14 · $25,153 | |||||||
Loading xslF345X03/doc4.xml…